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Introduction
The control of the diffusion of the MDRB in health
establishments is a priority.
Objectives
Our work studied the incidence of bacteremia due to
MDRB in a hospital environment.
Methods
Microbiological surveillance was led in three departments
of a teaching hospital during a period of six months
going from April till October 2012 and concerning only
blood cultures with diagnostic aim.
Results
During the study period, 123 patients were followed and
30 episodes of bacteremia were described that is 21% of all
the blood cultures taken. The average age of the patients
was 49 years±18.31 and the sex-ratio 0.66. The majority of
the patients (78.6%) were sent by a health care structure,
14.3% came from the place of residence and 7.1% were the
object of internal transfer. Thirty six percent of the
patients were admitted for a neurological disorder with an
average duration of stay of 19.66 days ±14.62. Positive
blood cultures were attributed to nosocomial infections in
22 cases (75.9%) with an average delay of acquisition of
14.55 days. On the bacteriological plan, the responsible
microorganisms were established: Enterobacteriaceae 17
(56.7%) among which 11 (64.7%) producing extended-
spectrum beta-lactamases (ESBL), non fermenting Gram-
negative bacteria 4 (13.3 %), Gram-positive bacteria 9
(30%) among which 4 methicillin-resistant Staphylococcus
aureus (MRSA). Klebsiella pneumoniae was the dominant
microorganism 8 (26.7%). The presence of a catheter was
identified in 7 cases of bacteremia associated with an
Enterobacteriaceaeproducing ESBL. The rate of attack
MDRB was 1.54 for 100 admissions and the incidence rate
was 1.66 for 1000 patient-days. After bacteremia, the
death rate was 61.5%.
Conclusion
The incidence of the MDRB during bacteremia is high
in our structure. A program of prevention of the diffu-
sion of the MDRB should be set up, accompanied with
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